Fibroblast growth factor 23 level modulates the hepatocyte’s alpha-2-HS-glycoprotein transcription through the inflammatory pathway TNFα/NFκB

INTRODUCTION: High serum levels of fibroblast growth factor 23 (FGF23) characterize chronic kidney disease (CKD) since its early stages and have been suggested to contribute to inflammation and cardiovascular disease. However, the mechanisms linking FGF23 with these pathological conditions remain st...

Descripción completa

Detalles Bibliográficos
Autores principales: Mattinzoli, Deborah, Li, Min, Castellano, Giuseppe, Ikehata, Masami, Armelloni, Silvia, Elli, Francesca Marta, Molinari, Paolo, Tsugawa, Koji, Alfieri, Carlo Maria, Messa, Piergiorgio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769965/
https://www.ncbi.nlm.nih.gov/pubmed/36569120
http://dx.doi.org/10.3389/fmed.2022.1038638

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769965/
https://www.ncbi.nlm.nih.gov/pubmed/36569120
http://dx.doi.org/10.3389/fmed.2022.1038638

Ejemplares similares